Spinal Cord Injury Research Program Clinical Trial Award
ID: 353184Type: Posted
Overview

Buyer

Dept. of the Army -- USAMRAA (DOD-AMRAA)

Eligible Applicants

Unrestricted

Funding Category

Science and Technology and other Research and Development

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/353184
Timeline
    Description

    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRAA), is offering the Fiscal Year 2024 Spinal Cord Injury Research Program Clinical Trial Award to support innovative clinical trials aimed at improving treatments for traumatic spinal cord injury (SCI). Applicants are encouraged to propose research that addresses one or more of the identified focus areas, such as spinal cord tissue protection, biomarker validation, and psychosocial issues, with an emphasis on community engagement and collaboration among military, academic, and community institutions. The program has an estimated total funding of $14.56 million, with awards potentially reaching up to $3 million in direct costs, and key deadlines include a pre-application due by May 20, 2024, followed by a full application submission by August 30, 2024. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.

    Point(s) of Contact
    help@eBRAP.org
    Files
    Title
    Posted
    HT942524SCIRPCTA-GG.pdf
    The Department of Defense (DOD) is announcing the Fiscal Year 2024 (FY24) Spinal Cord Injury Clinical Trial Award under the Congressionally Directed Medical Research Programs. This program supports research aimed at improving treatments for traumatic spinal cord injury (SCI), with $40 million available for grants. Proposals must address at least one of the identified focus areas, including spinal cord tissue protection at injury time, biomarker validation, psychosocial issues in SCI patients, and effective intervention development for various health complications. The submission process for applicants is two-fold: a pre-application due by May 20, 2024, followed by an invitation for full application submission by August 30, 2024. The SCIRP seeks to leverage partnerships between military, community, and academic institutions to enhance research validity and relevance. Awards may provide up to $3 million in direct costs, with emphasis on community engagement through collaborative research strategies. The application must showcase a comprehensive understanding of clinical trial protocols and the anticipated impact on military service members, veterans, and the broader SCI community, ensuring the proposed studies align with program objectives and regulatory compliance.
    Similar Opportunities
    Spinal Cord Injury (SCI) Model Systems National Data and Statistical Center
    Administration for Community Living
    The Administration for Community Living is offering a federal grant opportunity titled "Spinal Cord Injury (SCI) Model Systems National Data and Statistical Center." This grant aims to enhance the effectiveness of services under the Rehabilitation Act by developing methods and technologies that improve independent living and employment outcomes for individuals with spinal cord injuries. The selected center will be responsible for maintaining a national longitudinal database, ensuring high-quality data collection, and providing methodological support to SCI Model Systems Centers. The grant has an award ceiling of $800,000 and a floor of $795,000, with a project period of 60 months. Interested applicants can reach out to Radha Holavanahalli at Radha.Holavanahalli@acl.hhs.gov or call 202-795-7321 for more information, and the application deadline is expected to be around April 24, 2026.
    DOD USAMRDC FY23-FY27 BROAD AGENCY ANNOUNCEMENT for Extramural Medical Research
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the U.S. Army Medical Research and Development Command (USAMRDC), has announced the FY23-FY27 Broad Agency Announcement (BAA) for Extramural Medical Research, which is open for submissions from October 1, 2022, to September 30, 2027. This opportunity invites innovative research proposals that address critical military medical challenges, particularly in the areas of Military Infectious Diseases, Combat Casualty Care, and Military Operational Medicine, with a focus on enhancing medical practices for both military personnel and civilians. The BAA emphasizes the importance of collaboration with Department of Defense and Department of Veterans Affairs resources and requires adherence to strict submission guidelines via Grants.gov and the electronic Biomedical Research Application Portal (eBRAP). Interested applicants can submit pre-proposals at any time during the five-year period, with full proposals invited based on initial submissions, and should direct inquiries to the CDMRP Help Desk at help@eBRAP.org.
    Military and Civilian Partnership for Trauma Readiness Grant Program/Mission Zero
    Admin for Strategic Preparedness and Response
    The Administration for Strategic Preparedness and Response is offering the Military and Civilian Partnership for Trauma Readiness Grant Program, also known as the Mission Zero Act, to support high-acuity trauma centers in enhancing military-civilian partnerships for improved trauma care. This grant program aims to award up to 30 eligible trauma centers, enabling military trauma teams to provide full-time trauma and acute care services, thereby strengthening the nation's response to public health and medical emergencies. With an estimated total program funding of $4 million and an award ceiling of $4 million per grant, interested applicants, including nonprofits without 501(c)(3) status and hospitals, should note that the application period is expected to open on January 15, 2025, with a closing date of April 14, 2025. For further inquiries, applicants can contact Leslie Beck at 301-346-4857 or via email at leslie.beck@hhs.gov.
    Staff Research Program
    Dept of the Army -- Materiel Command
    The Department of the Army's Materiel Command is offering a funding opportunity for the Staff Research Program, aimed at engaging scientific staff in collaborative research with higher education institutions. This program seeks to enhance the professional competence of Army Research Office (ARO) scientists through hands-on, fundamental research in various scientific fields, including engineering, physical sciences, and life sciences, with a focus on advancing knowledge relevant to Army missions. Eligible applicants include institutions recognized for their scientific research capabilities, and the funding will be provided through cooperative agreements with award amounts ranging from $200,000 to $10 million. Proposals must be submitted via Grants.gov by June 2, 2030, and interested parties can contact Mr. William Creech at William.a.creech3.civ@army.mil for further information.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support rehabilitation scientists in establishing independent research careers. This grant aims to fund basic and clinical research projects that align with the mission of the National Center for Medical Rehabilitation Research (NCMRR), encouraging innovative studies in areas such as secondary data analysis, translational research, and the development of new technologies. The total estimated program funding is $200,000, with an award ceiling of $200,000, and applications are due by January 7, 2028. For further inquiries, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage for more details.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support early-stage rehabilitation scientists in establishing independent research careers. This grant aims to fund a variety of research projects, including secondary data analysis, methodology development, and translational research, particularly those that can generate preliminary data for future R01 applications. The initiative is crucial for fostering innovative rehabilitation research and enhancing the diversity of research talent in the biomedical field. The maximum funding amount is $200,000 over two years, with applications due by May 8, 2026. Interested applicants can find more information and application details at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), has announced a Broad Agency Announcement (BAA) for Extramural Biomedical and Human Performance Research and Development. This opportunity invites unrestricted applicants to submit proposals aimed at advancing biomedical research and development, with a focus on enhancing human performance. The program is critical for fostering innovation in science and technology, particularly in areas that support the Department of Defense's mission. The estimated total program funding is $10 million, with individual awards ranging from $750,000 to $50 million, and proposals are due by July 31, 2028. For further inquiries, applicants can contact the CDMRP Help Desk at help@eBRAP.org or by phone at 301-682-5507.
    BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for clinical studies aimed at advancing next-generation devices for recording and modulation in the human central nervous system, under the BRAIN Initiative. This initiative seeks to support small clinical trials that provide critical data necessary for the development of devices intended to treat central nervous system disorders, particularly those requiring an Investigational Device Exemption (IDE) from the FDA. The funding is crucial for enhancing neurotechnology and improving treatment outcomes, with NIH planning to allocate approximately $10 million annually for 5 to 7 awards, each with a maximum budget of $1.5 million per year for up to five years. Interested applicants can find more information and submit inquiries via grantsinfo@nih.gov, with applications due by September 28, 2026.
    National Paralysis Initiative
    Administration for Community Living
    The Administration for Community Living is forecasting a funding opportunity titled the National Paralysis Initiative, aimed at improving the health and quality of life for individuals living with paralysis and their support systems. This initiative seeks to enhance independence, create stronger support networks, and increase community participation for affected individuals through various funded activities. With an estimated total program funding of $1,185,000, the agency plans to award three cooperative agreements, each ranging from $350,000 to $400,000, with applications expected to be accepted starting March 1, 2022, and closing on May 2, 2022. Interested applicants can reach out to Elizabeth Leef at elizabeth.leef@acl.hhs.gov or (202) 475-2482 for further information.
    NFRP Outreach and Invitation for Response
    Dept. of the Army -- USAMRAA
    The Department of the Army, through the US Army Medical Research Acquisition Activity (USAMRAA), is forecasting an opportunity for a Research-based Other Transactions Agreement (rOTA) under the Neurofibromatosis Research Program (NFRP). This initiative aims to accelerate the clinical translation of basic research related to neurofibromatosis (NF) by conducting collaborative Phase I and II clinical trials focused on promising therapeutic agents for NF1, NF2, and schwannomatosis. Historically, this requirement has been addressed through assistance agreements, and the government is now seeking feedback on this proposed approach, emphasizing the need for cost-sharing arrangements and access to patient populations. Interested parties can direct inquiries to Jason D. Kuhns at jason.d.kuhns.civ@mail.mil, with the opportunity being part of the FY21 portfolio and requiring a demonstrated history of collaborative research among participants.